Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39.

Richard B. Gayle(IDEX Corporation (United States)), Aaron J. Marcus(Cornell University)
Journal of Clinical Investigation
May 1, 1998
Cited by 188


Related Papers